Filing Details

Accession Number:
0001209191-19-023084
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-03 16:15:51
Reporting Period:
2019-04-01
Accepted Time:
2019-04-03 16:15:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1505512 Regulus Therapeutics Inc. RGLS Pharmaceutical Preparations (2834) 264738379
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1762611 Ray Christopher Aker C/O Regulus Therapeutics
10628 Science Center Dr., #100
San Diego CA 92121
Sr. Vp & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-04-01 2,710 $0.98 6,287 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sale of shares of common stock under an existing 10b5-1 Plan to cover tax withholding obligations incurred in connection with the vesting of the restricted stock unit award received by the Reporting Person on 2/5/2019.